The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
Open accessAbstract
A prothrombotic coagulopathy is commonly found in critically ill COVID‐19 patients with acute respiratory distress syndrome (ARDS). A unique feature of COVID‐19 respiratory failure is a relatively preserved lung compliance and high Alveolar‐arterial oxygen gradient, with pathology reports consistently demonstrating diffuse pulmonary microthrombi on autopsy, all consistent with a vascular occlusive etiology of respiratory failure rather than the more classic findings of low‐compliance in ARDS. The COVID‐19 pandemic is overwhelming the world’s medical care capacity with unprecedented needs for mechanical ventilators and high rates of mortality once patients progress to needing mechanical ventilation, and in many environments including in parts of the United States the medical capacity is being exhausted. Fibrinolytic therapy has previously been used in a Phase 1 clinical trial that led to reduced mortality and marked improvements in oxygenation. Here we report a series of three patients with severe COVID‐19 respiratory failure who were treated with tissue plasminogen activator. All three patients had a temporally related improvement in their respiratory status, with one of them being a durable response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Han, H., Yang, L., Liu, R., Liu, F., Wu, K.-L., Li, J., Liu, X.-H., & Zhu, C.-L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0188 · Cited by 1,223
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
Konstantinides, S., Geibel, A., Heusel, G., Heinrich, F., & Kasper, W. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021274 · Cited by 997
HEPARIN PLUS ALTEPLASE COMPARED WITH HEPARIN ALONE IN PATIENTS WITH SUBMASSIVE PULMONARY EMBOLISM
Onstantinides, S. T. K., Eibel, A. N. G., Eusel, G. E. H., & Einrich, F. R. H. (2002) · Cited by 431
Clinical observation and management of COVID-19 patients
Li, T., Lu, H., & Zhang, W. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1741327 · Cited by 427
Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients
Wang, L., Zhao, L., Li, F., Ji, L., Zhang, L., Li, Q., Gu, J., Liang, S., Zhao, Q., Liu, J., et al. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13467 · Cited by 110
Cited by
Comorbidity and its Impact on Patients with COVID-19
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00363-4 · Cited by 1,548
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., et al. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00536-9 · Cited by 987
Lax, S. F., Skok, K., Zechner, P., Kessler, H. H., Kaufmann, N., Koelblinger, C., Vander, K., Bargfrieder, U., & Trauner, M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2566 · Cited by 730
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.029 · Cited by 694
Spyropoulos, A. C., Levy, J. H., Ageno, W., Connors, J. M., Hunt, B. J., Iba, T., Levi, M., Samama, C. M., Thachil, J., Giannis, D., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14929 · Cited by 657
Gibson, P. G., Qin, L., & Puah, S. H. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50674 · Cited by 598
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
McFadyen, J. D., Stevens, H., & Peter, K. (2020) · Circulation Research · doi:10.1161/circresaha.120.317447 · Cited by 592
Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study
Szekely, Y., Lichter, Y., Taieb, P., Banai, A., Hochstadt, A., Merdler, I., Gal Oz, A., Rothschild, E., Baruch, G., Peri, Y., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047971 · Cited by 590
Thomas, T., Stefanoni, D., Reisz, J. A., Nemkov, T., Bertolone, L., Francis, R. O., Hudson, K. E., Zimring, J. C., Hansen, K. C., Hod, E. A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140327 · Cited by 586
The pathophysiology of ‘happy’ hypoxemia in COVID-19
Dhont, S., Derom, E., Van Braeckel, E., Depuydt, P., & Lambrecht, B. N. (2020) · Respiratory Research · doi:10.1186/s12931-020-01462-5 · Cited by 544
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection
Pons, S., Fodil, S., Azoulay, E., & Zafrani, L. (2020) · Critical Care · doi:10.1186/s13054-020-03062-7 · Cited by 517
Barnes, G. D., Burnett, A., Allen, A., Blumenstein, M., Clark, N. P., Cuker, A., Dager, W. E., Deitelzweig, S. B., Ellsworth, S., Garcia, D., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02138-z · Cited by 467
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Miesbach, W., & Makris, M. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620938149 · Cited by 443
COVID-19-associated coagulopathy and disseminated intravascular coagulation
Asakura, H., & Ogawa, H. (2021) · International Journal of Hematology · doi:10.1007/s12185-020-03029-y · Cited by 442
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
Wright, F. L., Vogler, T. O., Moore, E. E., Moore, H. B., Wohlauer, M. V., Urban, S., Nydam, T. L., Moore, P. K., & McIntyre, R. C. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.05.007 · Cited by 418
Self-citationCuker, A., Tseng, E. K., Nieuwlaat, R., Angchaisuksiri, P., Blair, C., Dane, K., Davila, J., DeSancho, M. T., Diuguid, D., Griffin, D. O., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003763 · Cited by 408
Henry, B. M., Vikse, J., Benoit, S., Favaloro, E. J., & Lippi, G. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.027 · Cited by 383
Hess, D. C., Eldahshan, W., & Rutkowski, E. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00818-9 · Cited by 381
Emerging treatment strategies for COVID-19 infection
Gavriatopoulou, M., Ntanasis-Stathopoulos, I., Korompoki, E., Fotiou, D., Migkou, M., Tzanninis, I.-G., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00671-y · Cited by 326
Hanff, T. C., Mohareb, A. M., Giri, J., Cohen, J. B., & Chirinos, J. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25982 · Cited by 312
Cattaneo, M., Bertinato, E. M., Birocchi, S., Brizio, C., Malavolta, D., Manzoni, M., Muscarella, G., & Orlandi, M. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1712097 · Cited by 304
COVID-19 and Cancer: a Comprehensive Review
Gosain, R., Abdou, Y., Singh, A., Rana, N., Puzanov, I., & Ernstoff, M. S. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00934-7 · Cited by 285
Whyte, C. S., Morrow, G. B., Mitchell, J. L., Chowdary, P., & Mutch, N. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14872 · Cited by 273
COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
Keni, R., Alexander, A., Nayak, P. G., Mudgal, J., & Nandakumar, K. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00216 · Cited by 272
Thrombosis and Coagulopathy in COVID-19
Gómez-Mesa, J. E., Galindo-Coral, S., Montes, M. C., & Muñoz Martin, A. J. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100742 · Cited by 272
Kell, D. B., Laubscher, G. J., & Pretorius, E. (2022) · Biochemical Journal · doi:10.1042/bcj20220016 · Cited by 271
Madhavan, M. V., Bikdeli, B., Gupta, A., Jimenez, D., Burton, J. R., Der Nigoghossian, C., Chuich, T., Nouri, S. N., Dreyfus, I., Driggin, E., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1713152 · Cited by 258
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
Ahmed, S., Zimba, O., & Gasparyan, A. Y. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05275-1 · Cited by 251
Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
Li, X., Zhong, X., Wang, Y., Zeng, X., Luo, T., & Liu, Q. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250602 · Cited by 236
Cheung, S., Quiwa, J. C., Pillai, A., Onwu, C., Tharayil, Z. J., & Gupta, R. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.925753 · Cited by 90
Blood clots in COVID-19 patients: Simplifying the curious mystery
Biswas, S., Thakur, V., Kaur, P., Khan, A., Kulshrestha, S., & Kumar, P. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110371 · Cited by 74
O'Shea, A., Parakh, A., Hedgire, S., & Lee, S. I. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.20.24132 · Cited by 30
Modulation of endothelial organelle size as an antithrombotic strategy
Ferraro, F., Patella, F., Costa, J. R., Ketteler, R., Kriston‐Vizi, J., & Cutler, D. F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15084 · Cited by 19
Guillet, H., Gallet, R., Pham, V., D’Humières, T., Huguet, R., Lim, P., Michel, M., & Khellaf, M. (2021) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa488 · Cited by 17
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE: COVID-19 and Hematology
Kreidieh, F., & Temraz, S. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.078 · Cited by 7
Metadata
- Authors
- Wang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 18
- Issue
- 7
- Pages
- 1752-1755
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W3014627815
- Cited by
- 536
- References
- 12
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.